SCHEMBL6494910

SCHEMBL6494910

Nc1ccc(-c2nc3c(Cl)c(N)ccc3[nH]2)cc1

nearest known ligand 1.00 ✓ in ChEMBL — recovers established targets

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MEN1 O00255 9/20 1.00
▸ KMT2A Q03164 9/20 1.00
▸ MAPT P10636 8/20 1.00
▸ ALDH1A1 P00352 8/20 1.00
▸ NPC1 O15118 8/20 1.00
▸ SMN1; SMN2 Q16637 8/20 1.00
▸ KDM4E B2RXH2 7/20 1.00
▸ RAB9A P51151 7/20 1.00
▸ HPGD P15428 7/20 1.00
▸ GAA P10253 6/20 1.00
▸ HSD17B10 Q99714 5/20 1.00
▸ TP53 P04637 5/20 1.00
▸ GLA P06280 3/20 1.00
▸ CACNA1B Q00975 3/20 1.00
▸ APBA1 Q02410 3/20 1.00
▸ NPSR1 Q6W5P4 2/20 1.00
▸ CYP3A4 P08684 2/20 1.00
▸ CYP1A2 P05177 1/20 1.00
▸ CYP2C9 P11712 1/20 1.00
▸ CYP2C19 P33261 1/20 1.00

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6493952 0.84 ALDH1A1 (0.73) MEN1KMT2AMAPTALDH1A1NPC1
SCHEMBL11437721 0.81 RPS6KA3 (1.00) MEN1KMT2AMAPTALDH1A1NPC1
SCHEMBL6439291 0.77 PARP1 (0.64) MEN1KMT2AMAPTALDH1A1NPC1
SCHEMBL6333665 0.74 RPS6KA3 (0.77) MEN1KMT2AMAPTALDH1A1NPC1
SCHEMBL6494902 0.74 SMN1; SMN2 (0.59) MEN1KMT2AMAPTALDH1A1NPC1
SCHEMBL6492047 0.74 MEN1 (1.00) MEN1KMT2AMAPTALDH1A1NPC1
SCHEMBL31198946 0.73 MEN1 (0.57) MEN1KMT2AMAPTALDH1A1NPC1
SCHEMBL6507007 0.73 ALDH1A1 (0.57) MEN1KMT2AMAPTALDH1A1NPC1
SCHEMBL8768929 0.71 MAPT (0.54) MEN1KMT2AMAPTALDH1A1NPC1
SCHEMBL5761334 0.71 ALDH1A1 (0.68) MEN1KMT2AMAPTALDH1A1NPC1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050260126-A1 Diagnostic probes and remedies for diseases with accumulation of prion protein, and stains for prion protein BF RESEARCH INSTITUTE (JP) 2005-11-24 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050260126-A1 Diagnostic probes and remedies for diseases with accumulation of prion protein, and stains for prion protein PRNP, PRPH, PCNP MEN1 3565/4885KMT2A 3291/4885MAPT 7/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback